Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB

Monoclonal antibodies (mAb) are revolutionising the treatment of many different diseases. Given their differing mode of action compared to most conventional chemotherapeutics and small molecule inhibitors, they possess the potential to be independent of common modes of treatment resistance and can t...

Descripción completa

Detalles Bibliográficos
Autores principales: Stopforth, Richard J., Cleary, Kirstie L. S., Cragg, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891381/
https://www.ncbi.nlm.nih.gov/pubmed/26922075
http://dx.doi.org/10.1007/s10875-016-0247-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891381/
https://www.ncbi.nlm.nih.gov/pubmed/26922075
http://dx.doi.org/10.1007/s10875-016-0247-8

Ejemplares similares